LIDE at AACR Annual Meeting 2022
LIDE Biotech was very excited to be live at this year’s American Association of Cancer Research (AACR) Annual Meeting in New Orleans, April 8-13, 2022. The AACR Annual Meeting covers the latest advances in cancer research and LIDE highlighted some of our recent research at our booth and in our four poster presentations.
Our poster presentations:
| Title | Session | Category | Download links |
|---|---|---|---|
| PBMC Humanized Mice Model for Immuno-Oncology Drug Evaluation | Tumor Antigens, Antigen Presentation, and Tumor Immunity | Immunology | 1391 |
| Application of Conditionally Reprogrammed Cells in Cancer Model Establishment and New Target Identification | Cell Line and Animal Models | Tumor Biology | 1628 |
| MiniPDX®and Omics Analysis for ClinicalIndication and Biomarker Identification | Patient-Derived Xenografts | Tumor Biology | 3102 |
| Liquid Tumor Orthotopic PDX Models of Acute Leukemia | Patient-Derived Xenografts | Tumor Biology | 3103 |
This was our first year hosting a booth and it was a great way to connect with everyone and discuss LIDE’s latest technologies and how they can accelerate the drug research journey. We look forward to seeing everyone in Orlando in 2023!
